Association Between Daily Timing of Everolimus and Survival in High‐Risk HR +/ HER2 − Early Breast Cancer: A Sub‐Analysis of the UCBG‐UNIRAD Trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Enora Laas, Anne‐Sophie Hamy, Thomas Bachelot, Paul Gougis, Jérôme Lemonnier, Fabrice André, David Cameron, Judith Bliss, Sylvie Chabaud, Anne‐Claire Hardy‐Bessard, Magali Lacroix‐Triki, Djelila Allouache, Marc Debled, Mario Campone, Laurence Venat‐Bouvet, Paul Cottu, Mathilde Martinez, Julien Grenier, Florence Dalenc, Elise Dumas, Fabien Reyal, Bernard Asselain, Frédérique Penault‐Llorca, Francis Lévi, Sylvie Giacchetti
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet